Abstract：Objective To investigate the clinical effect and safety of bilevel positive airway pressure (BiPAP) combined with pulmonary surfactant (Poractant Alfa Injection [Curosurf]) in the treatment of neonatal respiratory distress syndrome (NRDS). Methods A total of 80 children with NRDS in Xuancheng People's Hospital of Anhui Province from August 2017 to December 2020 were selected. According to whether or not Curosurf was applied, they were divided into two groups, control group (40 cases) was treated with BiPAP, and observation group (40 cases) was treated with BiPAP combined with Curosurf. The clinical efficacy of two groups were compared, and the high pressure level (p-high), low pressure level (p-low), fraction of inspiration O2 (FiO2), arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2) and Oxygen therapy time, non-invasive ventilation time, clinical symptom relief time, and hospital stay of two groups were compared before treatment and two days after treatment. Results The total effective rate of observation group was higher than that of control group, and the difference was statistically significant (P < 0.05). After two days of treatment, P-high, FiO2 in observation group were lower than those before treatment, p-low in two groups were lower than those before treatment, P-high, P-low and FiO2 in observation group were lower than those in control group, and the differences were statistically significant (P < 0.05). After two days of treatment, PaO2 in two groups were higher than those before treatment, PaCO2 in two groups were lower than those before treatment, PaO2 in observation group was higher than that in control group, PaCO2 was lower than that in control group, and the differences were statistically significant (P < 0.05). The oxygen therapy time, non-invasive ventilation time, clinical symptom relief time and hospital stay in observation group were shorter than those in control group, and the differences were statistically significant (P < 0.05). Conclusion BiPAP combined with Curosurf has a significant effect on the treatment of NRDS, which can reduce mechanical ventilation parameters and promote the recovery of children with high safety.
汪丹丹 李亚林 万元. BiPAP联合肺表面活性物质治疗新生儿呼吸窘迫综合征的临床效果及安全性[J]. 中国医药导报, 2021, 18(30): 114-117.
WANG Dandan LI Yalin WAN Yuan. Clinical effect and safety of BiPAP combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome#br#. 中国医药导报, 2021, 18(30): 114-117.
京公网安备 11010502046598号